XWAR
ENE
Market cap146mUSD
Oct 09, Last price
20.20PLN
1D
0.00%
1Q
5.21%
Jan 2017
108.25%
IPO
304.00%
Name
Centrum Medyczne Enel Med SA
Chart & performance
P/E
44.31
P/S
0.67
EPS
0.46
Div yield, %
—
Shrs. gr., 5y
3.71%
Rev. gr., 5y
16.40%
Revenues
854m
+16.13%
Net income
13m
-11.75%
CFO
99m
-3.75%
Dividend
Jun 09, 20150.1 PLN/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Centrum Medyczne ENEL-MED S.A., a prominent healthcare provider established in 1993, operates from its Warsaw, Poland base, offering an extensive array of medical services nationwide. These provisions encompass specialized consultations, dentistry, orthopedics, infertility treatments, physical rehabilitation, psychological support, and comprehensive diagnostic capabilities. Additionally, they provide vaccinations, emergency care, and surgical interventions to their patients.
Key people
Jacek Rozwadowski
Chief Executive Officer, Chairman of the Management Board · since 2018
Finance Director, Member of the Management Board · since 2018
Bartosz Rozwadowski
Member of the Management Board · since 2018
Anna Rozwadowska
Chairman of the Supervisory Board · since 2009
Anna Piszcz
Independent Member of the Supervisory Board · since 2006
Andrzej Salasinski
Independent Member of the Supervisory Board · since 2016
Adam Ciuhak
Independent Member of the Supervisory Board · since 2010
Member of the Supervisory Board · since 2021
Independent Member of the Supervisory Board · since 2010
Joanna Szymanska-Bulska
Member of the Supervisory Board · since 2024
Headquarters & legal address
Warszawa Słomińskiego 19/524
Warszawa, 14 00-195
PL
Warszawa, 14 00-195
PL
Valuation
Title PLN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||